Chlorpromazine versus placebo for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

blogs: 2 blogs
twitter: 25 tweeters
peer_reviews: 1 peer review site
weibo: 1 weibo user

facebook: 1 Facebook page
wikipedia: 2 Wikipedia pages
video: 1 video uploader

Citations

dimensions_citation: 60 Dimensions

Readers on

mendeley: 348 Mendeley

Summary Blogs Twitter Peer reviews Weibo Facebook Wikipedia Video Dimensions citations

So far, Dimensions has found 60 publications that cite this research output.

60

The most recent citing publications are shown below. View all 60 publications that cite this research output on Dimensions.

A dual dopaminergic therapy with L-3,4-dihydroxyphenylalanine and chlorpromazine for the treatment of blepharospasm, a focal dystonia: Possible implications for striosomal D1 signaling

Article in Frontiers in Neurology (July 2022)

Elder’s life course theory and person‐centered research: A lens for conducting ethical nursing research and mental health nursing practice with older adults aging with the diagnosis of schizophrenia

Article in Journal of Psychiatric and Mental Health Nursing (January 2022)

Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis

Article in Schizophrenia Research (September 2021)